Evidence map›Paper›PMID 32069360›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections.

Joe Amoah, Elizabeth A Stuart, Sara E Cosgrove, Anthony D Harris, Jennifer H Han, Ebbing Lautenbach, Pranita D Tamma

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joe AmoahThe Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, Maryland, USA.
Elizabeth A StuartThe Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, Baltimore, Maryland, USA.
Sara E CosgroveThe Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, Maryland, USA.
Anthony D HarrisThe University of Maryland School of Medicine, Department of Epidemiology and Public Health, Baltimore, Maryland, USA.
Jennifer H HanGlaxoSmithKline, Rockville, Maryland, USA.
Ebbing LautenbachThe University of Pennsylvania School of Medicine, Department of Medicine, Philadelphia, Pennsylvania, USA.
Pranita D TammaThe Johns Hopkins University School of Medicine, Department of Pediatrics, Baltimore, Maryland, USA.

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
K24 Clinical Research in Antimicrobial Resistance and Hospital EpidemiologyK24AI079040 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRIS, ANTHONY D · 2009 to 2018
$1.8M
Mentoring and patient-oriented research in antimicrobial resistanceK24AI080942 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2009 to 2013
$853k
The Use of MALDI TOF for the Rapid Detection of Carbapenemases from Clinical IsolatesK23AI127935 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TAMMA, PRANITA · 2017 to 2020
$734k
NIAID NIH HHS K23 AI127935NIAID NIH HHS K24 AI079040NIAID NIH HHS K24 AI080942NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

backgroundPropensity score methods are increasingly being used in the infectious diseases literature to estimate causal effects from observational data. However, there remains a general gap in understanding among clinicians on how to critically review observational studies that have incorporated these analytic techniques.

methodsUsing a cohort of 4967 unique patients with Enterobacterales bloodstream infections, we sought to answer the question "Does transitioning patients with gram-negative bloodstream infections from intravenous to oral therapy impact 30-day mortality?" We conducted separate analyses using traditional multivariable logistic regression, propensity score matching, propensity score inverse probability of treatment weighting, and propensity score stratification using this clinical question as a case study to guide the reader through (1) the pros and cons of each approach, (2) the general steps of each approach, and (3) the interpretation of the results of each approach.

results2161 patients met eligibility criteria with 876 (41%) transitioned to oral therapy while 1285 (59%) remained on intravenous therapy. After repeating the analysis using the 4 aforementioned methods, we found that the odds ratios were broadly similar, ranging from 0.84-0.95. However, there were some relevant differences between the interpretations of the findings of each approach.

conclusionsPropensity score analysis is overall a more favorable approach than traditional regression analysis when estimating causal effects using observational data. However, as with all analytic methods using observational data, residual confounding will remain; only variables that are measured can be accounted for. Moreover, propensity score analysis does not compensate for poor study design or questionable data accuracy.

Indexed as

SepsisCohort StudiesHumansLogistic ModelsPropensity ScoreRegression Analysiscausal inferencelogistic regressionobservational datapropensity score matchingpropensity score weighting

Identifiers

PMID32069360
PMCPMC7713675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.